Literature DB >> 20003920

Duration of Vi antibodies in participants vaccinated with Typhim Vi (Typhoid Vi polysaccharide vaccine) in an area not endemic for typhoid fever.

James E Froeschle1, Michael D Decker.   

Abstract

After a single injection of Typhim Vi (typhoid Vi polysaccharide vaccine), serum antibody concentrations were monitored for 3 years in 37 adults who resided where typhoid fever was not endemic. Anti-Vi antibody concentrations declined progressively during the study, to levels that support the current US recommendation for revaccination every 2 years. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20003920     DOI: 10.1016/j.vaccine.2009.11.051

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  2 in total

1.  Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial.

Authors:  Katherine Theiss-Nyland; Mila Shakya; Rachel Colin-Jones; Merryn Voysey; Nicola Smith; Abhilasha Karkey; Sabina Dongol; Dikshya Pant; Yama G Farooq; Kathleen M Neuzil; Shrijana Shrestha; Buddha Basnyat; Andrew J Pollard
Journal:  Clin Infect Dis       Date:  2019-03-07       Impact factor: 9.079

2.  Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infection Among Bangladeshi Children: A Protocol for a Phase IIIb Trial.

Authors:  Katherine Theiss-Nyland; Firdausi Qadri; Rachel Colin-Jones; K Zaman; Farhana Khanam; Xinxue Liu; Merryn Voysey; Arifuzzaman Khan; Nazmul Hasan; Fahim Ashher; Yama G Farooq; Andrew J Pollard; John D Clemens
Journal:  Clin Infect Dis       Date:  2019-03-07       Impact factor: 9.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.